Evaluation of total oxidant and antioxidant status in localized and generalized vitiligo

Clinical and Experimental Dermatology

Volumn 38, Issue 7, 2013, Pages 701-706

  Akoglu, G ^a   Emre, S ^a   Metin, A ^a   Akbas, A ^a   Yorulmaz, A ^a   Isikoglu, S ^a   Sener, S ^a   Kilinc, F ^a  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; OXIDIZING AGENT;

ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; VITILIGO;

ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; VITILIGO; YOUNG ADULT;

EID: 84884837478     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12054     Document Type: Article

References (34)

1. Handa S, Kaur I,. Vitiligo: clinical findings in 1436 patients. J Dermatol 1999; 26: 653-7.
2. Schallreuter KU, Gibbons NC, Zothner C, et al,. Hydrogen peroxide-mediated oxidative stress disrupts calcium binding on calmodulin: more evidence for oxidative stress in vitiligo. Biochem Biophys Res Commun 2007; 17: 70-5.
3. Taïeb A,. Intrinsic and extrinsic pathomechanisms in vitiligo. Pigment Cell Res 2000; 13 (Suppl. 8): 41-7.
4. Taïeb A, Morice-Picard F, Jouary T, et al,. Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non-segmental vitiligo. Pigment Cell Melanoma Res 2008; 21: 646-52.
5. Bowers RR, Nguyen B, Buckner S, et al,. Role of antioxidants in the survival of normal and vitiliginous avian melanocytes. Cell Mol Biol (Noisy-le-grand) 1999; 45: 1065-74.
6. Hasse S, Gibbons NC, Rokos H, et al,. Perturbed 6-tetrahydrobiopterin recycling via decreased dihydropteridine reductase in vitiligo: more evidence for H2O2 stress. J Invest Dermatol 2004; 122: 307-13.
7. Maresca V, Roccella M, Roccella F, et al,. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 1997; 109: 310-13.
8. Schallreuter KU, Bahadoran P, Picardo M, et al,. Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol 2008; 17: 139-40.
9. 2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc 1999; 4: 91-6.
10. Schallreuter KU, Wood JM, Berger J,. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991; 97: 1081-5.
11. Erel O,. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005; 38: 1103-11.
12. Esen C, Alkan BA, Kirnap M, et al,. The effects of chronic periodontitis and rheumatoid arthritis on serum and gingival crevicular fluid total antioxidant/oxidant status and oxidative stress index. J Periodontol 2012; 83: 773-9.
13. Erel O,. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin Biochem 2004; 37: 277-85.
14. Tarpey MM, Wink DA, Grisham MB,. Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol 2004; 286: R431-44.
15. Chu CY, Liu YL, Chiu HC, Jee SH,. Dopamine-induced apoptosis in human melanocytes involves generation of reactive oxygen species. Br J Dermatol 2006; 154: 1071-9.
16. Westerhof W, d'Ischia M,. Vitiligo puzzle: the pieces fall in place. Pigment Cell Res 2007; 20: 345-59.
17. 2-mediated oxidation: a possible repair mechanism for DNA damage. FASEB J 2009; 23: 3790-807.
18. Arican O, Kurutas EB,. Oxidative stress in the blood of patients with active localized vitiligo. Acta Dermatovenerol Alp Panonica Adriat 2008; 17: 12-16.
19. Sravani PV, Babu NK, Gopal KV, et al,. Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin. Indian J Dermatol Venereol Leprol 2009; 75: 268-71.
20. Yildirim M, Baysal V, Inaloz HS, et al,. The role of oxidants and antioxidants in generalized vitiligo. J Dermatol 2003; 30: 104-8.
21. Picardo M, Passi S, Morrone A, et al,. Antioxidant status in the blood of patients with active vitiligo. Pigment Cell Res 1994; 7: 110-15.
22. Agrawal D, Shajil EM, Marfatia YS, Begum R,. Study on the antioxidant status of vitiligo patients of different age groups in Baroda. Pigment Cell Res 2004; 17: 289-94.
23. Jain A, Mal J, Mehndiratta V, et al,. Study of oxidative stres in vitiligo. Indian J Clin Biochem 2011; 26: 78-81.
24. Dammak I, Boudaya S,., Ben Abdallah F, et al,. Antioxidant enzymes and lipid peroxidation at the tissue level in patients with stable and active vitiligo. Int J Dermatol 2009; 48: 476-80.
25. Passi S, Grandinetti M, Maggio F, et al,. Epidermal oxidative stress in vitiligo. Pigment Cell Res 1998; 11: 81-5.
26. Koca R, Armutcu F, Altinyazar HC, Gürel A,. Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo. Clin Exp Dermatol 2004; 29: 406-9.
27. Dell'Anna ML, Ottaviani M, Bellei B, et al,. Membrane lipid defects are responsible for the generation of reactive oxygen species in peripheral blood mononuclear cells from vitiligo patients. J Cell Physiol 2010; 223: 187-93.
28. Dell'Anna ML, Mastrofrancesco A, Sala R, et al,. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial. Clin Exp Dermatol 2007; 32: 631-6.
29. Dell'Anna ML, Maresca V, Briganti S, et al,. Mitochondrial impairment in peripheral blood mononuclear cells during the active phase of vitiligo. J Invest Dermatol 2001; 117: 908-13.
30. Jimbow K, Chen H, Park JS, Thomas PD,. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol 2001; 144: 55-65.
31. Boisseau-Garsaud AM, Garsaud P, Lejoly-Boisseau H, et al,. Increase in total blood antioxidant status and selenium levels in black patients with active vitiligo. Int J Dermatol 2002; 41: 640-2.
32. Giovannelli L, Bellandi S, Pitozzi V, et al,. Increased oxidative DNA damage in mononuclear leukocytes in vitiligo. Mutat Res 2004; 556: 101-6.
33. Khan R, Satyam A, Gupta S, et al,. Circulatory levels of antioxidants and lipid peroxidation in Indian patients with generalized and localized vitiligo. Arch Dermatol Res 2009; 301: 731-7.
34. Shajil EM, Begum R,. Antioxidant status of segmental and non-segmental vitiligo. Pigment Cell Res 2006; 19: 179-80.